title: Peptide accumulations in proximal endbulbs of transected axons.
abstract: Axons proximal to a transection develop into enlarged, but presumed 'passive' endbulb structures. In previous studies, we observed that proximal stumps of transected sciatic nerves accumulate discrete and striking deposits of calcitonin gene-related peptide (CGRP) that have apparent direct and local actions on nearby microvessels. In this work, we provide evidence that CGRP, in the company of several additional peptides, are deposited through 'arrested' anterograde transport into axon endbulbs that develop after transection. In proximal stump tips of rat sciatic nerves transected 48 h earlier, CGRP accumulation colocalized with a label for neurofilament that was accentuated at axon tips, but was prevented by a concurrent more proximal sciatic section. Similarly, interruption of CGRP deposition eliminated its apparent actions on local microvessels following injury. CGRP accumulation was also observed in sural nerve proximal stump tips, indicating its presence in sensory axons despite the known declines in the sensory neuronal synthesis of CGRP that occur following axotomy. Peptide accumulation was not unique to CGRP, with a similar pattern of anterograde accumulation observed for substance P (SP), neuropeptide Y (NPY) and galanin. Deposited peptides and perhaps other axonal constituents in the milieu of a peripheral nerve injury may be associated with important local physiological actions in the regenerative microenvironment.
authors.affiliation: Department of Clinical Neurosciences and the Neuroscience Research Group, University of Calgary, Alberta, Calgary, Canada. dzochodn@ucalgary.ca
authors.forename: D W
authors.initials: DW
authors.lastname: Zochodne
authors.forename: C
authors.initials: C
authors.lastname: Cheng
authors.forename: M
authors.initials: M
authors.lastname: Miampamba
authors.forename: K
authors.initials: K
authors.lastname: Hargreaves
authors.forename: K A
authors.initials: KA
authors.lastname: Sharkey
mesh_terms: D000818:Animals; D001369:Axons / Q000378:metabolism*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism*; D006940:Hyperemia / Q000209:etiology / Q000503:physiopathology; D008297:Male; D009437:Neuralgia / Q000209:etiology / Q000503:physiopathology; D009463:Neuroma / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D009479:Neuropeptides / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve / Q000098:blood supply / Q000293:injuries*; D013373:Substance P / Q000378:metabolism; D013497:Sural Nerve / Q000293:injuries* / Q000473:pathology
chemical_list: D009479:Neuropeptides; D013373:Substance P; D015740:Calcitonin Gene-Related Peptide